Sanshin Nutrition Technology Co., Ltd.

Sanshin Nutrition Technology Co., Ltd.

About

Company description

  • Colostrum Pathogenic Recognition Protein, CPRP, will attach to non-specific antigens in gut, enter the gut mucous membrane and release signals to immune cells, which stimulates immune cells and induce the immunity against antigens.
  • Instead of enhancing the cell antioxidant ability or stimulating the immune cells, CPRP can induce antibody IgA production. 
  • Now, this protein has been applied into the treatment of human influenza, enterovirus, and common cold, which all shows the positive results. 
  • We are now conducting the clinic theory of human influenza and enterovirus.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer; Retailer
Affiliated categories: Immunology |Tablets |Natural Extracts More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 9J62 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Sanshin Nutrition Technology Co., Ltd.

Sanshin Nutrition Technology Co., Ltd.

Contact information

Address

Telephone

Website

View all contact information